| Name | Title | Contact Details |
|---|
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions.
Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services. Our purpose is to enable people with allergies to live normal lives. With more than 1,400 employees worldwide, a presence in 75 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer plc is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France). With complementary strengths, joint heritage and reputations, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy.
Since its establishment in 2004, Ray has been leading the global market in digital dentistry by proposing a new standard for dental imaging solutions through state-of-the-art technology.
AltaThera Pharmaceuticals is a Chicago-based specialty pharmaceutical company focused on identifying, acquiring, developing, and commercializing therapies addressing unmet medical needs of critical care patients and those with severe, and often rare, disorders for which few effective treatments are available.
DYSIS is a computer-aided colposcope with innovative cervical mapping to help healthcare professionals clearly detect cervical lesions